Interestingly, studies among IBD patients revealed that the level of CLDN2 is increased [28], and the levels of CLDN3, CLDN4, CLDN7, and OCLN decreased [29], which complies with our outcomes in the animal model. The gene discussed is CLDN3; the disease is inflammatory bowel disease.